SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-028229
Filing Date
2024-02-27
Accepted
2024-02-27 16:29:36
Documents
1
Group Members
DR. JAMES I. HEALYDR. MAHA KATABISOFINNOVA MANAGEMENT VIII, L.L.C.SOFINNOVA MANAGEMENT X, L.P.SOFINNOVA MANAGEMENT X-A, L.L.C.SOFINNOVA VENTURE PARTNERS X, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm246499d1_sc13da.htm SC 13D/A 171088
  Complete submission text file 0001104659-24-028229.txt   172974
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners VIII, L.P. (Filed by) CIK: 0001524064 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Subject) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90138 | Film No.: 24687329
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)